Clinical and radiomic features for predicting the treatment response of repetitive transcranial magnetic stimulation in major neurocognitive disorder: Results from a randomized controlled trial.

Hum Brain Mapp · 2022 · PMC9704797 · PMID 35912517

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

marginally significantp = .05actually significant

Compared with sham rTMS group, the BDNF level in active rTMS group demonstrated a marginally significant increase ( p = .05) at T1.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.